Uptake of the lateral flow urine LAM test in Europe and Central Asia

INTRODUCTION: Since 2015 (updated in 2019), the WHO has recommended to include the commercial lateral flow urine lipoarabinomannan TB test (LF-LAM), AlereLAM, in the diagnostic toolkit for severely ill people living with HIV. METHODS: To assess the current use and barriers to the implementation of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kraef, C., Yedilbayev, A., Seguy, N., Bentzon, A., Podlekareva, D., Cirillo, D. M., van der Werf, M. J., Kirk, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union Against Tuberculosis and Lung Disease 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423022/
https://www.ncbi.nlm.nih.gov/pubmed/35996279
http://dx.doi.org/10.5588/ijtld.21.0656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423022/
https://www.ncbi.nlm.nih.gov/pubmed/35996279
http://dx.doi.org/10.5588/ijtld.21.0656

Ejemplares similares